{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:00:33Z","timestamp":1783702833087,"version":"3.55.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.amjms.2024.06.002","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T20:31:55Z","timestamp":1718397115000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Full decongestion in acute heart failure therapy"],"prefix":"10.1016","volume":"368","author":[{"given":"Chandan","family":"Buttar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Alai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris N.","family":"Matanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Stencel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry H.","family":"Le Jemtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.amjms.2024.06.002_bib0001","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart failure epidemiology and outcomes statistics: a report of the heart failure society of America","volume":"29","author":"Bozkurt","year":"2023","journal-title":"J Card Fail"},{"issue":"18","key":"10.1016\/j.amjms.2024.06.002_bib0002","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001585","article-title":"Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction","volume":"8","author":"Straw","year":"2021","journal-title":"Open Heart"},{"issue":"12","key":"10.1016\/j.amjms.2024.06.002_bib0004","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2006.09.011","article-title":"Congestion in acute heart failure syndromes: an essential target of evaluation and treatment","volume":"119","author":"Gheorghiade","year":"2006","journal-title":"Am. J. Med."},{"issue":"36","key":"10.1016\/j.amjms.2024.06.002_bib0005","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.amjms.2024.06.002_bib0006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.amjms.2024.06.002_bib0007","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002922","article-title":"Fluid volume overload and congestion in heart failure: time to reconsider pathophysiology and how volume is assessed","volume":"9","author":"Miller","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190993","article-title":"The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort","volume":"13","author":"Conway","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.amjms.2024.06.002_bib0009","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.amjms.2024.06.002_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0011","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","volume":"8","author":"Lala","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.amjms.2024.06.002_bib0012","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCHEARTFAILURE.111.961789","article-title":"Sympathetically mediated changes in capacitance: redistribution of the venous reservoir as a cause of decompensation","volume":"4","author":"Fallick","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.amjms.2024.06.002_bib0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11897-013-0135-y","article-title":"Chemohypersensitivity and autonomic modulation of venous capacitance in the pathophysiology of acute decompensated heart failure","volume":"10","author":"Burchell","year":"2013","journal-title":"Curr Heart Fail Rep"},{"issue":"8","key":"10.1016\/j.amjms.2024.06.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006817","article-title":"Role of volume redistribution in the congestion of heart failure","volume":"6","author":"Fudim","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"10.1016\/j.amjms.2024.06.002_bib0015","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/CIRCULATIONAHA.107.690768","article-title":"Patterns of weight change preceding hospitalization for heart failure","volume":"116","author":"Chaudhry","year":"2007","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.amjms.2024.06.002_bib0016","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1161\/CIRCULATIONAHA.107.729608","article-title":"Can we predict and prevent the onset of acute decompensated heart failure?","volume":"116","author":"Wolfel","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0017","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cardfail.2020.12.006","article-title":"Diuresis-related weight loss reflects interstitial compartment decongestion with minimal impact on intravascular volume expansion or outcomes in post-acute heart failure: metrics of decongestion and volume status","volume":"27","author":"Miller","year":"2021","journal-title":"J Card Fail"},{"issue":"3","key":"10.1016\/j.amjms.2024.06.002_bib0018","first-page":"304","article-title":"Plasma expansion in surgical patients with high central venous pressure (CVP); the relationship of blood volume to hematocrit, CVP, pulmonary wedge pressure, and cardiorespiratory changes","volume":"78","author":"Baek","year":"1975","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0019","first-page":"8","article-title":"Circulating blood volume measurements correlate poorly with pulmonary artery catheter measurements","volume":"67","author":"Yamauchi","year":"2008","journal-title":"Hawaii Med J"},{"issue":"8","key":"10.1016\/j.amjms.2024.06.002_bib0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11936-014-0330-5","article-title":"Treatment approaches to congestion relief in acute decompensated HF: insights After DOSE-AHF and CARRESS-HF","volume":"16","author":"Shakar","year":"2014","journal-title":"Curr Treat Options Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.amjms.2024.06.002_bib0021","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ejhf.2384","article-title":"Worsening renal function in acute heart failure in the context of diuretic response","volume":"24","author":"Emmens","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.amjms.2024.06.002_bib0022","doi-asserted-by":"crossref","first-page":"660","DOI":"10.12968\/bjon.2021.30.11.660","article-title":"Audit of the appropriateness and accuracy of fluid intake and output monitoring: experience in a tertiary hospital","volume":"30","author":"Lim","year":"2021","journal-title":"Br J Nurs"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002370","article-title":"Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure","volume":"9","author":"Testani","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2015.06.017","article-title":"Intravenous diuretic therapy for the management of heart failure and volume overload in a multidisciplinary outpatient unit","volume":"4","author":"Buckley","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0025","article-title":"Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure","volume":"9","author":"Testani","year":"2016","journal-title":"Circulation: Heart Failure"},{"issue":"2","key":"10.1016\/j.amjms.2024.06.002_bib0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the heart failure association of the European society of cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.amjms.2024.06.002_bib0027","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","article-title":"Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial","volume":"29","author":"Ter Maaten","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0028","first-page":"348","article-title":"A diabetes-associated genetic variant is associated with diastolic dysfunction and cardiovascular disease","volume":"7","author":"Molvin","year":"2020","journal-title":"ESC Heart Fail"},{"issue":"11","key":"10.1016\/j.amjms.2024.06.002_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113192","article-title":"Brain natriuretic peptide biomarkers in current clinical and therapeutic scenarios of heart failure","volume":"11","author":"Alcidi","year":"2022","journal-title":"J Clin Med"},{"issue":"16","key":"10.1016\/j.amjms.2024.06.002_bib0030","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCULATIONAHA.117.029882","volume":"137","author":"Stienen","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.amjms.2024.06.002_bib0031","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC state-of-the-art review","volume":"75","author":"Felker","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjms.2024.06.002_bib0032","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11897-015-0273-5","article-title":"Current approach to decongestive therapy in acute heart failure","volume":"12","author":"Martens","year":"2015","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"10.1016\/j.amjms.2024.06.002_bib0033","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial","volume":"329","author":"Mentz","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.amjms.2024.06.002_bib0034","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/ejhf.2988","article-title":"Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: a post-hoc analysis of the CLOROTIC trial","volume":"25","author":"Trull\u00e0s","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10.1016\/j.amjms.2024.06.002_bib0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"issue":"37","key":"10.1016\/j.amjms.2024.06.002_bib0036","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1093\/eurheartj\/ehad557","article-title":"Renal function and decongestion with acetazolamide in acute decompensated heart failure: the ADVOR trial","volume":"44","author":"Meekers","year":"2023","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.amjms.2024.06.002_bib0037","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","article-title":"Combining loop with thiazide diuretics for decompensated heart failure: the CLOROTIC trial","volume":"44","author":"Trull\u00e0s","year":"2023","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.amjms.2024.06.002_bib0038","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehx035","article-title":"Renal sodium avidity in heart failure: from pathophysiology to treatment strategies","volume":"38","author":"Mullens","year":"2017","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.amjms.2024.06.002_bib0039","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jchf.2020.03.009","article-title":"Acute kidney function declines in the context of decongestion in acute decompensated heart failure","volume":"8","author":"McCallum","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"24","key":"10.1016\/j.amjms.2024.06.002_bib0040","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2011.10.910","article-title":"Diuretics and ultrafiltration in acute decompensated heart failure","volume":"59","author":"Felker","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11897-021-00538-7","article-title":"Impact of loop diuretic on outcomes in patients with heart failure and reduced ejection fraction","volume":"19","author":"Antonietta","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.amjms.2024.06.002_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-199100413-00003","article-title":"How do loop diuretics act?","volume":"41","author":"Wittner","year":"1991","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5049\/EBP.2015.13.1.17","article-title":"Loop diuretics in clinical practice","volume":"13","author":"Oh","year":"2015","journal-title":"Electrolytes & Blood Pressure: E & BP"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0044","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.120.15205","article-title":"Pathophysiology of diuretic resistance and its implications for the management of chronic heart failure","volume":"76","author":"Wilcox","year":"2020","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.amjms.2024.06.002_bib0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ahj.2014.12.009","article-title":"A reappraisal of loop diuretic choice in heart failure patients","volume":"169","author":"Buggey","year":"2015","journal-title":"Am. Heart J."},{"issue":"9","key":"10.1016\/j.amjms.2024.06.002_bib0046","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.amjms.2024.06.002_bib0047","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1681\/ASN.2006060620","article-title":"Acid-base transport by the renal proximal tubule","volume":"17","author":"Boron","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.amjms.2024.06.002_bib0048","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.amjms.2024.06.002_bib0049","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1681\/ASN.2016111178","article-title":"Compensatory distal reabsorption drives diuretic resistance in human heart failure","volume":"28","author":"Rao","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0050","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1681\/ASN.2010080827","article-title":"The WNK kinase network regulating sodium, potassium, and blood pressure","volume":"22","author":"Hoorn","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0051","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ejhf.2066","article-title":"Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure","volume":"23","author":"Boorsma","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0052","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jamacardio.2022.4348","article-title":"Population-level implications of sodium-glucose cotransporter-2 inhibitors for heart failure with preserved ejection fraction in the US","volume":"8","author":"Talha","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"31","key":"10.1016\/j.amjms.2024.06.002_bib0053","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","article-title":"Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics","volume":"44","author":"Yeoh","year":"2023","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.amjms.2024.06.002_bib0054","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.amjms.2024.06.002_bib0055","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.amjms.2024.06.002_bib0056","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2024.06.002_bib0057","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10741-020-10024-2","article-title":"Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors","volume":"26","author":"Margonato","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0058","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCULATIONAHA.120.050391","article-title":"Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: results of DAPA-HF","volume":"143","author":"Jhund","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0059","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.123.064346","article-title":"Critical analysis of the effects of SGLT2 inhibitors on renal tubular sodium, water and chloride homeostasis and their role in influencing heart failure outcomes","volume":"148","author":"Packer","year":"2023","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjms.2024.06.002_bib0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99123","article-title":"Canagliflozin triggers the FGF23\/1, 25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study","volume":"3","author":"Blau","year":"2018","journal-title":"JCI insight"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0061","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007046","article-title":"Interaction between the sodium-glucose\u2013linked transporter 2 inhibitor dapagliflozin and the loop diuretic bumetanide in normal human subjects","volume":"7","author":"Wilcox","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.amjms.2024.06.002_bib0062","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jamacardio.2023.1090","article-title":"Safety and efficacy of empagliflozin and diuretic use in patients with heart failure and preserved ejection fraction: a post hoc analysis of the EMPEROR-preserved trial","volume":"8","author":"Butler","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"31","key":"10.1016\/j.amjms.2024.06.002_bib0063","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/eurheartj\/ehad283","article-title":"Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial","volume":"44","author":"Chatur","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0064","first-page":"35","article-title":"Efficacy and safety of empagliflozin according to background diuretic use in HFrEF: post-hoc analysis of EMPEROR-Reduced","volume":"12","author":"Dhingra","year":"2024","journal-title":"Heart Fail"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0065","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.122.059725","article-title":"Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: results from the EMPULSE trial","volume":"146","author":"Kosiborod","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.amjms.2024.06.002_bib0066","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.amjms.2024.06.002_bib0067","first-page":"2099","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"issue":"10354","key":"10.1016\/j.amjms.2024.06.002_bib0068","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"issue":"10254","key":"10.1016\/j.amjms.2024.06.002_bib0069","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.amjms.2024.06.002_bib0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007048","article-title":"Effect of empagliflozin as an add-On therapy on decongestion and renal function in patients with diabetes hospitalized for acute decompensated heart failure: a prospective randomized controlled study","volume":"14","author":"Tamaki","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0071","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"14","key":"10.1016\/j.amjms.2024.06.002_bib0072","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and safety of dapaglifozen in patients with acute heart failure","volume":"83","author":"Cox","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.amjms.2024.06.002_bib0073","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0074","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0075","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"9","key":"10.1016\/j.amjms.2024.06.002_bib0076","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"9","key":"10.1016\/j.amjms.2024.06.002_bib0077","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jacc.2020.12.057","article-title":"Spironolactone in patients with heart failure, preserved ejection fraction, and worsening renal function","volume":"77","author":"Beldhuis","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.amjms.2024.06.002_bib0078","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1002\/ehf2.14086","article-title":"Dyskalemia in people at increased risk for heart failure: findings from the heart \u2018OMics\u2019 in AGEing (HOMAGE) trial","volume":"9","author":"Monzo","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"37","key":"10.1016\/j.amjms.2024.06.002_bib0079","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1093\/eurheartj\/ehad522","article-title":"Mineralocorticoid receptor antagonists with sodium-glucose co-transporter-2 inhibitors in heart failure: a meta-analysis","volume":"44","author":"Banerjee","year":"2023","journal-title":"Eur Heart J"},{"issue":"8 Supp B","key":"10.1016\/j.amjms.2024.06.002_bib0080","first-page":"9","article-title":"The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition","volume":"13","author":"Atlas","year":"2007","journal-title":"J Manag Care Pharm"},{"issue":"3","key":"10.1016\/j.amjms.2024.06.002_bib0081","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.63.3.645","article-title":"Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure","volume":"63","author":"Dzau","year":"1981","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.amjms.2024.06.002_bib0082","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM199908193410806","article-title":"Hormones and hemodynamics in heart failure","volume":"341","author":"Schrier","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.amjms.2024.06.002_bib0083","doi-asserted-by":"crossref","first-page":"F1115","DOI":"10.1152\/ajprenal.00337.2002","article-title":"Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure","volume":"284","author":"Chen","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.amjms.2024.06.002_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2022.100465","article-title":"Renin-angiotensin-aldosterone system activation and diuretic response in ambulatory patients with heart failure","volume":"4","author":"Amatruda","year":"2022","journal-title":"Kidney Med"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0085","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002333","article-title":"Influence of titration of neurohormonal antagonists and blood pressure reduction on renal function and decongestion in decompensated heart failure","volume":"9","author":"Kula","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.amjms.2024.06.002_bib0086","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00380-022-02160-6","article-title":"Relationship between early drop in systolic blood pressure, worsening renal function, and in-hospital mortality in patients with heart failure: a retrospective, observational study","volume":"38","author":"Kido","year":"2023","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.amjms.2024.06.002_bib0087","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/CRD.0000000000000093","article-title":"Sacubitril\/Valsartan","volume":"24","author":"Sible","year":"2016","journal-title":"Cardiol Rev"},{"issue":"11","key":"10.1016\/j.amjms.2024.06.002_bib0088","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.amjms.2024.06.002_bib0089","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.amjms.2024.06.002_bib0090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin\u2013neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.amjms.2024.06.002_bib0091","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"issue":"9266","key":"10.1016\/j.amjms.2024.06.002_bib0092","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"The Lancet"},{"issue":"21","key":"10.1016\/j.amjms.2024.06.002_bib0093","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Medi"},{"issue":"4","key":"10.1016\/j.amjms.2024.06.002_bib0094","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1067\/mhj.2001.116768","article-title":"Regression of left ventricular remodeling in chronic heart failure: comparative and combined effects of captopril and carvedilol","volume":"142","author":"Khattar","year":"2001","journal-title":"Am Heart J"},{"issue":"suppl_C","key":"10.1016\/j.amjms.2024.06.002_bib0095","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1093\/eurheartj\/sul009","article-title":"Beta-blockade in CHF: pathophysiological considerations","volume":"8","author":"Silke","year":"2006","journal-title":"Eur Heart J Suppl"},{"issue":"10367","key":"10.1016\/j.amjms.2024.06.002_bib0096","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial","volume":"400","author":"Mebazaa","year":"2022","journal-title":"The Lancet"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924012734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924012734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T14:54:26Z","timestamp":1723647266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962924012734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0002962924012734"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.06.002","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Full decongestion in acute heart failure therapy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}